FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:426-431 February 15, 1996 Number 7 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Clinical trials of antiretroviral drugs can take years to complete because the outcomes measured are progression to the acquired immunodeficiency syndrome (AIDS) or death. Trials could be accelerated by the use of end points such as changes in CD4+ lymphocyte counts and plasma levels of human immunodeficiency virus type 1 (HIV-1) RNA and ₂-microglobulin, but there is uncertainty about whether these surrogate measures are valid predictors of disease progression.

Methods We analyzed data from the Veterans Affairs Cooperative Study on AIDS, which compared immediate with deferred zidovudine therapy. Patients' plasma levels of HIV-1 RNA and ₂-microglobulin were measured in stored plasma.

Results Among the 129 patients in the immediate-treatment group, 34 had disease that progressed to AIDS, as compared with 57 of the 141 patients in the deferred-treatment group (P = 0.03). Progression to AIDS correlated strongly with base-line CD4+ lymphocyte counts (P = 0.001) and plasma levels of HIV-1 RNA (P<0.001), but not with base-line levels of ₂-microglobulin (P = 0.14). A decrease of at least 75 percent in the plasma level of HIV-1 RNA over the first six months of zidovudine therapy accounted for 59 percent of the benefit of treatment, defined as the absence of progression to AIDS (95 percent confidence interval, 13 to 112 percent). Plasma ₂-microglobulin levels and CD4+ lymphocyte counts explained less of the effect of treatment. A 75 percent decrease in the plasma HIV-1 RNA level plus a 10 percent increase in the CD4+ lymphocyte count could explain 79 percent of the treatment effect (95 percent confidence interval, 27 to 145 percent).

Conclusions Treatment-induced changes in the plasma HIV-1 RNA level and the CD4+ lymphocyte count, taken together, are valid predictors of the clinical progression of HIV-related disease and can be used to assess the efficacy of zidovudine and possibly other antiretroviral drugs as well.

Source Information

From the Department of Medicine, West Los Angeles Veterans Affairs Medical Center and University of California at Los Angeles Medical School, Los Angeles (W.A.O.); the Veterans Affairs Cooperative Studies Program Coordinating Center, West Haven, Conn. (P.M.H.); the University of North Carolina, Chapel Hill (D.M.); Glaxo, Inc., Research Triangle Park, N.C. (J.E., A.H., S.B., M.R.); the New York Veterans Affairs Medical Center and New York University School of Medicine, New York (M.S.S.); and the Durham, N.C., Veterans Affairs Medical Center and Duke University Medical Center, Durham, N.C. (J.D.H.). Presented in part at the 10th International Conference on AIDS, Yokohama, Japan, August 7–12, 1994, and the 2nd National Conference on Human Retroviruses and Related Infections, Washington, D.C., January 29–February 2, 1995.

Address reprint requests to Dr. O'Brien at the West Los Angeles VA Medical Center, 11301 Wilshire Blvd., Los Angeles, CA 90073.

Full Text of this Article

Related Letters:

Viral Load and Response to Treatment of HIV
Ioannidis J. P.A., Cappelleri J. C., Lau J., De Gruttola V., Fleming T., Coombs R., Fessel W. J., O'Brien W. A., Hartigan P., Hamilton J. D.
Extract | Full Text  
N Engl J Med 1996; 334:1671-1673, Jun 20, 1996. Correspondence

This article has been cited by other articles:

• Fernandez, C. S., Chan, A. C., Kyparissoudis, K., De Rose, R., Godfrey, D. I., Kent, S. J. (2009). Peripheral NKT Cells in Simian Immunodeficiency Virus-Infected Macaques. J. Virol. 83: 1617-1624 [Abstract] [Full Text]  
• Chaudhary, M., Kashyap, B., Gautam, H., Saini, S., Bhalla, P. (2008). Use of Surrogate Markers to Predict the HIV Disease Stage and Time to Initiate Antiretroviral Therapy in Developing Countries. J Int Assoc Physicians AIDS Care (Chic Ill) 7: 259-264 [Abstract]  
• Chen, P., Hubner, W., Spinelli, M. A., Chen, B. K. (2007). Predominant Mode of Human Immunodeficiency Virus Transfer between T Cells Is Mediated by Sustained Env-Dependent Neutralization-Resistant Virological Synapses. J. Virol. 81: 12582-12595 [Abstract] [Full Text]  
• Perrin, L., Pawlotsky, J. M., Bouvier-Alias, M., Sarrazin, C., Zeuzem, S., Colucci, G. (2006). Multicenter Performance Evaluation of a New TaqMan PCR Assay for Monitoring Human Immunodeficiency Virus RNA Load. J. Clin. Microbiol. 44: 4371-4375 [Abstract] [Full Text]  
• Staszewski, S., Babacan, E., Stephan, C., Haberl, A., Carlebach, A., Gute, P., Klauke, S., Hermschulte, Y., Stuermer, M., Dauer, B., for the Frankfurt HIV Cohort, (2006). The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy. J Antimicrob Chemother 58: 1024-1030 [Abstract] [Full Text]  
• Ylitalo, N., Brogly, S., Hughes, M. D., Nachman, S., Dankner, W., Van Dyke, R., Seage, G. R. III, for the Pediatric AIDS Clinical Trials Group Proto, (2006). Risk Factors for Opportunistic Illnesses in Children With Human Immunodeficiency Virus in the Era of Highly Active Antiretroviral Therapy. Arch Pediatr Adolesc Med 160: 778-787 [Abstract] [Full Text]  
• Salimnia, H., Moore, E. C., Crane, L. R., MacArthur, R. D., Fairfax, M. R. (2005). Discordance between Viral Loads Determined by Roche COBAS AMPLICOR Human Immunodeficiency Virus Type 1 Monitor (Version 1.5) Standard and Ultrasensitive Assays Caused by Freezing Patient Plasma in Centrifuged Becton-Dickinson Vacutainer Brand Plasma Preparation Tubes. J. Clin. Microbiol. 43: 4635-4639 [Abstract] [Full Text]  
• Chohan, B., Lang, D., Sagar, M., Korber, B., Lavreys, L., Richardson, B., Overbaugh, J. (2005). Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels. J. Virol. 79: 6528-6531 [Abstract] [Full Text]  
• Knorr, A. L., Srivastava, R. (2005). Evaluation of HIV-1 kinetic models using quantitative discrimination analysis. Bioinformatics 21: 1668-1677 [Abstract] [Full Text]  
• Nachman, S., Gona, P., Dankner, W., Weinberg, A., Yogev, R., Gershon, A., Rathore, M., Read, J. S., Huang, S., Elgie, C., Hudgens, K., Hughes, W. (2005). The Rate of Serious Bacterial Infections Among HIV-Infected Children With Immune Reconstitution Who Have Discontinued Opportunistic Infection Prophylaxis. Pediatrics 115: e488-e494 [Abstract] [Full Text]  
• Sanders, G. D., Bayoumi, A. M., Sundaram, V., Bilir, S. P., Neukermans, C. P., Rydzak, C. E., Douglass, L. R., Lazzeroni, L. C., Holodniy, M., Owens, D. K. (2005). Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy. NEJM 352: 570-585 [Abstract] [Full Text]  
• Hu, P., Reuben, D. B., Crimmins, E. M., Harris, T. B., Huang, M.-H., Seeman, T. E. (2004). The Effects of Serum Beta-Carotene Concentration and Burden of Inflammation on All-Cause Mortality Risk in High-Functioning Older Persons: MacArthur Studies of Successful Aging. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59: M849-M854 [Abstract] [Full Text]  
• Bosch, R. J, Pierce, C., Spritzler, J., Kendall, M. A, Jacobson, J. M, Schock, B., Siminski, S. (2004). A reporting tool for real-time assessment of study data availability. Clin Trials 1: 339-340 [Abstract]  
• Rouet, F., Sakarovitch, C., Msellati, P., Elenga, N., Montcho, C., Viho, I., Blanche, S., Rouzioux, C., Dabis, F., Leroy, V. (2003). Pediatric Viral Human Immunodeficiency Virus Type 1 RNA Levels, Timing of Infection, and Disease Progression in African HIV-1-Infected Children. Pediatrics 112: e289-289 [Abstract] [Full Text]  
• Antunes, R., Figueiredo, S., Bartolo, I., Pinheiro, M., Rosado, L., Soares, I., Lourenco, H., Taveira, N. (2003). Evaluation of the Clinical Sensitivities of Three Viral Load Assays with Plasma Samples from a Pediatric Population Predominantly Infected with Human Immunodeficiency Virus Type 1 Subtype G and BG Recombinant Forms. J. Clin. Microbiol. 41: 3361-3367 [Abstract] [Full Text]  
• Thaker, H K, Snow, M H (2003). HIV viral suppression in the era of antiretroviral therapy. Postgrad. Med. J. 79: 36-42 [Abstract] [Full Text]  
• DeVange Panteleeff, D., Emery, S., Richardson, B. A., Rousseau, C., Benki, S., Bodrug, S., Kreiss, J. K., Overbaugh, J. (2002). Validation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay with Genital Swabs and Breast Milk Samples. J. Clin. Microbiol. 40: 3929-3937 [Abstract] [Full Text]  
• Hale-Donze, H., Greenwell-Wild, T., Mizel, D., Doherty, T. M., Chatterjee, D., Orenstein, J. M., Wahl, S. M. (2002). Mycobacterium avium Complex Promotes Recruitment of Monocyte Hosts for HIV-1 and Bacteria. J. Immunol. 169: 3854-3862 [Abstract] [Full Text]  
• Porcu, P., Eisenbeis, C. F., Pelletier, R. P., Davies, E. A., Baiocchi, R. A., Roychowdhury, S., Vourganti, S., Nuovo, G. J., Marsh, W. L., Ferketich, A. K., Henry, M. L., Ferguson, R. M., Caligiuri, M. A. (2002). Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8+ T-cell restoration. Blood 100: 2341-2348 [Abstract] [Full Text]  
• Kostrikis, L. G., Touloumi, G., Karanicolas, R., Pantazis, N., Anastassopoulou, C., Karafoulidou, A., Goedert, J. J., Hatzakis, A. (2002). Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load. J. Virol. 76: 10099-10108 [Abstract] [Full Text]  
• Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., Pau, A. K. (2002). Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV. ANN INTERN MED 137: 381-433 [Abstract] [Full Text]  
• Goto, Y., Nishimura, Y., Baba, K., Mizuno, T., Endo, Y., Masuda, K., Ohno, K., Tsujimoto, H. (2002). Association of Plasma Viral RNA Load with Prognosis in Cats Naturally Infected with Feline Immunodeficiency Virus. J. Virol. 76: 10079-10083 [Abstract] [Full Text]  
• Patel, P. G., Yu Kimata, M. T., Biggins, J. E., Wilson, J. M., Kimata, J. T. (2002). Highly Pathogenic Simian Immunodeficiency Virus mne Variants That Emerge during the Course of Infection Evolve Enhanced Infectivity and the Ability To Downregulate CD4 but Not Class I Major Histocompatibility Complex Antigens. J. Virol. 76: 6425-6434 [Abstract] [Full Text]  
• Jordan, R., Gold, L., Cummins, C., Hyde, C. (2002). Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. BMJ 324: 757-757 [Abstract] [Full Text]  
• Weusten, J. J. A. M., Carpay, W. M., Oosterlaken, T. A. M., van Zuijlen, M. C. A., van de Wiel, P. A. (2002). Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons. Nucleic Acids Res 30: e26-e26 [Abstract] [Full Text]  
• Edwards, B. H., Bansal, A., Sabbaj, S., Bakari, J., Mulligan, M. J., Goepfert, P. A. (2002). Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma. J. Virol. 76: 2298-2305 [Abstract] [Full Text]  
• Yamano, Y., Nagai, M., Brennan, M., Mora, C. A., Soldan, S. S, Tomaru, U., Takenouchi, N., Izumo, S., Osame, M., Jacobson, S. (2002). Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99: 88-94 [Abstract] [Full Text]  
• Hogg, R. S., Yip, B., Chan, K. J., Wood, E., Craib, K. J. P., O'Shaughnessy, M. V., Montaner, J. S. G. (2001). Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy. JAMA 286: 2568-2577 [Abstract] [Full Text]  
• Pomerantz, R. J. (2001). Initiating Antiretroviral Therapy During HIV Infection: Confusion and Clarity. JAMA 286: 2597-2599 [Full Text]  
• Kahn, J. G., Haile, B., Kates, J., Chang, S. (2001). Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid. AJPH 91: 1464-1473 [Abstract] [Full Text]  
• Schumann, G., Hermankova, M., Cannon, K., Mankowski, J. L., Boeke, J. D. (2001). Therapeutic Effect of a Gag-Nuclease Fusion Protein against Retroviral Infection In Vivo. J. Virol. 75: 7030-7041 [Abstract] [Full Text]  
• Erali, M., Page, S., Reimer, L. G., Hillyard, D. R. (2001). Human Immunodeficiency Virus Type 1 Drug Resistance Testing: a Comparison of Three Sequence-Based Methods. J. Clin. Microbiol. 39: 2157-2165 [Abstract] [Full Text]  
• de Baar, M. P., van Dooren, M. W., de Rooij, E., Bakker, M., van Gemen, B., Goudsmit, J., de Ronde, A. (2001). Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O. J. Clin. Microbiol. 39: 1378-1384 [Abstract] [Full Text]  
• Albert, J. M, Yun, H. (2001). Statistical advances in AIDS therapy trials. Stat Methods Med Res 10: 85-100 [Abstract]  
• Raab, G. M, Parpia, T. (2001). Random effects models for HIV marker data: practical approaches with currently available software. Stat Methods Med Res 10: 101-116 [Abstract]  
• Becker, N. G, Marschner, I. C (2001). Advances in medical statistics arising from the AIDS epidemic. Stat Methods Med Res 10: 117-140 [Abstract]  
• Hader, S. L., Smith, D. K., Moore, J. S., Holmberg, S. D. (2001). HIV Infection in Women in the United States: Status at the Millennium. JAMA 285: 1186-1192 [Abstract] [Full Text]  
• Gilbert, P. B., DeGruttola, V., Hammer, S. M., Kuritzkes, D. R. (2001). Virologic and Regimen Termination Surrogate End Points in AIDS Clinical Trials. JAMA 285: 777-784 [Abstract] [Full Text]  
• Fultz, P. N., Vance, P. J., Endres, M. J., Tao, B., Dvorin, J. D., Davis, I. C., Lifson, J. D., Montefiori, D. C., Marsh, M., Malim, M. H., Hoxie, J. A. (2001). In Vivo Attenuation of Simian Immunodeficiency Virus by Disruption of a Tyrosine-Dependent Sorting Signal in the Envelope Glycoprotein Cytoplasmic Tail. J. Virol. 75: 278-291 [Abstract] [Full Text]  
• Ikuta, K., Suzuki, S., Horikoshi, H., Mukai, T., Luftig, R. B. (2000). Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis. Microbiol. Mol. Biol. Rev. 64: 725-745 [Abstract] [Full Text]  
• Emery, S., Bodrug, S., Richardson, B. A., Giachetti, C., Bott, M. A., Panteleeff, D., Jagodzinski, L. L., Michael, N. L., Nduati, R., Bwayo, J., Kreiss, J. K., Overbaugh, J. (2000). Evaluation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D Isolates from Kenya. J. Clin. Microbiol. 38: 2688-2695 [Abstract] [Full Text]  
• John, G. C., Rousseau, C., Dong, T., Rowland-Jones, S., Nduati, R., Mbori-Ngacha, D., Rostron, T., Kreiss, J. K., Richardson, B. A., Overbaugh, J. (2000). Maternal SDF1 3'A Polymorphism Is Associated with Increased Perinatal Human Immunodeficiency Virus Type 1 Transmission. J. Virol. 74: 5736-5739 [Abstract] [Full Text]  
• Paredes, R., Mocroft, A., Kirk, O., Lazzarin, A., Barton, S. E., van Lunzen, J., Katzenstein, T. L., Antunes, F., Lundgren, J. D., Clotet, B., for the EuroSIDA Study Group, (2000). Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe: Results From the EuroSIDA Study. Arch Intern Med 160: 1123-1132 [Abstract] [Full Text]  
• Erb, P., Battegay, M., Zimmerli, W., Rickenbach, M., Egger, M., for the Swiss HIV Cohort Study, (2000). Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus-Infected Cohort. Arch Intern Med 160: 1134-1140 [Abstract] [Full Text]  
• Jagodzinski, L. L., Wiggins, D. L., McManis, J. L., Emery, S., Overbaugh, J., Robb, M., Bodrug, S., Michael, N. L. (2000). Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests. J. Clin. Microbiol. 38: 1247-1249 [Abstract] [Full Text]  
• Christopherson, C., Kidane, Y., Conway, B., Krowka, J., Sheppard, H., Kwok, S. (2000). PCR-Based Assay To Quantify Human Immunodeficiency Virus Type 1 DNA in Peripheral Blood Mononuclear Cells. J. Clin. Microbiol. 38: 630-634 [Abstract] [Full Text]  
• Popper, S. J., Sarr, A. D., Guèye-Ndiaye, A., Mboup, S., Essex, M. E., Kanki, P. J. (2000). Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo. J. Virol. 74: 1554-1557 [Abstract] [Full Text]  
• Holodniy, M., Rainen, L., Herman, S., Yen-Lieberman, B. (2000). Stability of Plasma Human Immunodeficiency Virus Load in VACUTAINER PPT Plasma Preparation Tubes during Overnight Shipment. J. Clin. Microbiol. 38: 323-326 [Abstract] [Full Text]  
• Campbell, T. B., Sevin, A., Coombs, R. W., Peterson, G. C., Rosandich, M., Kuritzkes, D. R., Mladenovic, J., Landay, A., Wong, R., Ambruso, D., Miles, S., Pomerantz, R. J., Schooley, R. T., the Adult AIDS Clinical Trials Group 285 Study Tea, (2000). Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Blood 95: 48-55 [Abstract] [Full Text]  
• Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., Manion, D. J., Ruiz, N. M., The Study 006 Team, (1999). Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults. NEJM 341: 1865-1873 [Abstract] [Full Text]  
• Engels, E. A., Rosenberg, P. S., O'Brien, T. R., Goedert, J. J., for the Multicenter Hemophilia Cohort Study, (1999). Plasma HIV Viral Load in Patients with Hemophilia and Late-Stage HIV Disease: A Measure of Current Immune Suppression. ANN INTERN MED 131: 256-264 [Abstract] [Full Text]  
• Kirstein, L. M., Mellors, J. W., Rinaldo, C. R. Jr., Margolick, J. B., Giorgi, J. V., Phair, J. P., Dietz, E., Gupta, P., Sherlock, C. H., Hogg, R., Montaner, J. S. G., Muñoz, A. (1999). Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma. J. Clin. Microbiol. 37: 2428-2433 [Abstract] [Full Text]  
• Michael, N. L., Herman, S. A., Kwok, S., Dreyer, K., Wang, J., Christopherson, C., Spadoro, J. P., Young, K. K. Y., Polonis, V., McCutchan, F. E., Carr, J., Mascola, J. R., Jagodzinski, L. L., Robb, M. L. (1999). Development of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 and Performance of an Improved AMPLICOR HIV-1 MONITOR Test with Isolates of Diverse Subtypes. J. Clin. Microbiol. 37: 2557-2563 [Abstract] [Full Text]  
• Lucas, G. M., Chaisson, R. E., Moore, R. D. (1999). Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions. ANN INTERN MED 131: 81-87 [Abstract] [Full Text]  
• de Baar, M. P., van der Schoot, A. M., Goudsmit, J., Jacobs, F., Ehren, R., van der Horn, K. H. M., Oudshoorn, P., de Wolf, F., de Ronde, A. (1999). Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target. J. Clin. Microbiol. 37: 1813-1818 [Abstract] [Full Text]  
• Hockett, R. D., Michael Kilby, J., Derdeyn, C. A., Saag, M. S., Sillers, M., Squires, K., Chiz, S., Nowak, M. A., Shaw, G. M., Bucy, R. P. (1999). Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA. JEM 189: 1545-1554 [Abstract] [Full Text]  
• Neilson, J. R., John, G. C., Carr, J. K., Lewis, P., Kreiss, J. K., Jackson, S., Nduati, R. W., Mbori-Ngacha, D., Panteleeff, D. D., Bodrug, S., Giachetti, C., Bott, M. A., Richardson, B. A., Bwayo, J., Ndinya-Achola, J., Overbaugh, J. (1999). Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya. J. Virol. 73: 4393-4403 [Abstract] [Full Text]  
• Ginocchio, C. C., Tetali, S., Washburn, D., Zhang, F., Kaplan, M. H. (1999). Comparison of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma as Measured by the NucliSens Nucleic Acid Sequence-Based Amplification and Quantiplex Branched-DNA Assays. J. Clin. Microbiol. 37: 1210-1212 [Abstract] [Full Text]  
• Easterbrook, P. J., Goodall, R. L., Babiker, A. G., Yu, L. M., Smith, D., Cooper, D. A., Gazzard, B. G. (1999). Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?. J Antimicrob Chemother 43: 379-388 [Abstract] [Full Text]  
• Murphy, D. G., Gonin, P., Fauvel, M. (1999). Reproducibility and Performance of the Second-Generation Branched-DNA Assay in Routine Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma. J. Clin. Microbiol. 37: 812-814 [Abstract] [Full Text]  
• Gomes, P., Taveira, N. C., Pereira, J. M., Antunes, F., Ferreira, M. O. S., Lourenço, M. H. (1999). Quantitation of Human Immunodeficiency Virus Type 2 DNA in Peripheral Blood Mononuclear Cells by Using a Quantitative-Competitive PCR Assay. J. Clin. Microbiol. 37: 453-456 [Abstract] [Full Text]  
• Boriskin, Y. S, Sharland, M., Dalton, R., duMont, G., Booth, J. C (1999). Viral loads in dual infection with HIV-1 and cytomegalovirus. Arch. Dis. Child. 80: 132-136 [Abstract] [Full Text]  
• Schenkel, A. R., Uno, H., Pauza, C. D. (1999). Asymptomatic Simian Immunodeficiency Virus Infection Decreases Blood CD4+ T Cells by Accumulating Recirculating Lymphocytes in the Lymphoid Tissues. J. Virol. 73: 601-607 [Abstract] [Full Text]  
• Lyles, C. M., Vlahov, D., Farzadegan, H., Astemborski, J., Margolick, J. B., Masters, B. A., Schroeder, J., Quinn, T. C. (1998). Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk Groups. J. Clin. Microbiol. 36: 3647-3652 [Abstract] [Full Text]  
• Grovit-Ferbas, K., Ferbas, J., Gudeman, V., Sadeghi, S., Goetz, M. B., Giorgi, J. V., Chen, I. S. Y., O'Brien, W. A. (1998). Potential Contributions of Viral Envelope and Host Genetic Factors in a Human Immunodeficiency Virus Type 1-Infected Long-Term Survivor. J. Virol. 72: 8650-8658 [Abstract] [Full Text]  
• Achour, A., Landureau, J.-C., Salerno-Concalves, R., Mazière, J.-C., Zagury, D. (1998). Restoration of Immune Response by a Cationic Amphiphilic Drug (AY 9944) In Vitro: A New Approach To Chemotherapy against Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother. 42: 2482-2491 [Abstract] [Full Text]  
• Sun, R., Ku, J., Jayakar, H., Kuo, J.-C., Brambilla, D., Herman, S., Rosenstraus, M., Spadoro, J. (1998). Ultrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma. J. Clin. Microbiol. 36: 2964-2969 [Abstract] [Full Text]  
• Petersen, L. A (1998). Recent advances: General medicine. BMJ 317: 792-795 [Full Text]  
• Gelfand, J. M., Rudikoff, D., Lebwohl, M., Klotman, M. E. (1998). Effect of UV-B Phototherapy on Plasma HIV Type 1 RNA Viral Level: A Self-controlled Prospective Study. Arch Dermatol 134: 940-945 [Abstract] [Full Text]  
• Klapper, P. E., Jungkind, D. L., Fenner, T., Antinozzi, R., Schirm, J., Blanckmeister, C. (1998). Multicenter International Work Flow Study of an Automated Polymerase Chain Reaction Instrument. Clin. Chem. 44: 1737-1739 [Full Text]  
• Schacker, T., Ryncarz, A. J., Goddard, J., Diem, K., Shaughnessy, M., Corey, L. (1998). Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1-Infected Men. JAMA 280: 61-66 [Abstract] [Full Text]  
• Vener, T., Nygren, M., Andersson, A., Uhlén, M., Albert, J., Lundeberg, J. (1998). Use of Multiple Competitors for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma. J. Clin. Microbiol. 36: 1864-1870 [Abstract] [Full Text]  
• Chan, K. S., Revicki, D. A. (1998). Changes in Surrogate Laboratory Markers, Clinical Endpoints, and Health-Related Quality of Life in Patients Infected with the Human Immunodeficiency Virus. Eval Health Prof 21: 265-281 [Abstract]  
• Roger, M. (1998). Influence of host genes on HIV-1 disease progression. FASEB J. 12: 625-632 [Abstract] [Full Text]  
• Albaran, R. G., Webber, J., Steffes, C. P. (1998). CD4 Cell Counts as a Prognostic Factor of Major Abdominal Surgery in Patients Infected With the Human Immunodeficiency Virus. Arch Surg 133: 626-631 [Abstract] [Full Text]  
• Macher, A. M., Goosby, E. P. (1998). Primary HIV Infection/Acute Retroviral Syndrome: An Intervention Opportunity for Correctional Facilities. J Correct Health Care 5: 51-62 [Abstract]  
• Wei, Q., Fultz, P. N. (1998). Extensive Diversification of Human Immunodeficiency Virus Type 1 Subtype B Strains during Dual Infection of a Chimpanzee That Progressed to AIDS. J. Virol. 72: 3005-3017 [Abstract] [Full Text]  
• Bartlett, J. A. (1998). Strategies of Antiretroviral Therapy in Adults. The Oncologist 3: 111-118 [Abstract] [Full Text]  
• Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., Holmberg, S. D., The HIV Outpatient Study Investigators, (1998). Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection. NEJM 338: 853-860 [Abstract] [Full Text]  
• Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J. P., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S. G. (1998). Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy. JAMA 279: 450-454 [Abstract] [Full Text]  
• Yerly, S., Perneger, T. V., Hirschel, B., Dubuis, O., Matter, L., Malinverni, R., Furrer, H., Perrin, L., for the Swiss HIV Cohort Study, (1998). A Critical Assessment of the Prognostic Value of HIV-1 RNA Levels and CD4+ Cell Counts in HIV-Infected Patients. Arch Intern Med 158: 247-252 [Abstract] [Full Text]  
• Drusano, G. L., Stein, D. S. (1998). Mathematical Modeling of the Interrelationship of CD4 Lymphocyte Count and Viral Load Changes Induced by the Protease Inhibitor Indinavir. Antimicrob. Agents Chemother. 42: 358-361 [Abstract] [Full Text]  
• Boscardin, W J., Taylor, J. M., Law, N. (1998). Longitudinal models for AIDS marker data. Stat Methods Med Res 7: 13-27 [Abstract]  
• Agostoni, C., Zuccotti, G. V., Riva, E., Decarlis, S., Bernardo, L., Bruzzese, M. G, Giovannini, M. (1998). Low Levels of Linoleic Acid in Plasma Total Lipids of HIV-1 Seropositive Children. J. Am. Coll. Nutr. 17: 25-29 [Abstract] [Full Text]  
• Vlahov, D., Graham, N., Hoover, D., Flynn, C., Bartlett, J. G., Margolick, J. B., Lyles, C. M., Nelson, K. E., Smith, D., Holmberg, S., Farzadegan, H. (1998). Prognostic Indicators for AIDS and Infectious Disease Death in HIV-Infected Injection Drug Users: Plasma Viral Load and CD4+ Cell Count. JAMA 279: 35-40 [Abstract] [Full Text]  
• Kimata, J. T., Mozaffarian, A., Overbaugh, J. (1998). A Lymph Node-Derived Cytopathic Simian Immunodeficiency Virus Mne Variant Replicates in Nonstimulated Peripheral Blood Mononuclear Cells. J. Virol. 72: 245-256 [Abstract] [Full Text]  
• Rabkin, J. G., Ferrando, S. (1997). A 'Second Life' Agenda: Psychiatric Research Issues Raised by Protease Inhibitor Treatments for People With the Human Immunodeficiency Virus or the Acquired Immunodeficiency Syndrome. Arch Gen Psychiatry 54: 1049-1053 [Abstract]  
• Hestdal, K., Aukrust, P., Muller, F., Lien, E., Bjerkeli, V., Espevik, T., Froland, S. S. (1997). Dysregulation of Membrane-Bound Tumor Necrosis Factor-alpha and Tumor Necrosis Factor Receptors on Mononuclear Cells in Human Immunodeficiency Virus Type 1 Infection: Low Percentage of p75-Tumor Necrosis Factor Receptor Positive Cells in Patients With Advanced Disease and High Viral Load. Blood 90: 2670-2679 [Abstract] [Full Text]  
• Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A., Chodakewitz, J. A., Deutsch, P., Holder, D., Schleif, W. A., Condra, J. H. (1997). Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy. NEJM 337: 734-739 [Abstract] [Full Text]  
• Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., Volberding, P. A. (1997). Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society--USA Panel. JAMA 277: 1962-1969 [Abstract]  
• Noone, A., Goldberg, D. (1997). Antenatal Hiv testing: what now?. BMJ 314: 1429-1429 [Full Text]  
• Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupancic, M., Gebhard, K., Henry, K., Zhang, Z., Mills, R., McDade, H., Goudsmit, J., Danner, S. A., Haase, A. T. (1997). Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection. Science 276: 960-964 [Abstract] [Full Text]  
• Lange, J. M. (1997). Current Problems and the Future of Antiretroviral Drug Trials. Science 276: 548-550 [Abstract] [Full Text]  
• (1997). Major advances in the treatment of HIV-1 infection. DTB 35: 25-29 [Abstract] [Full Text]  
• Cohn, J. A. (1997). Recent advances: hiv infection–I. BMJ 314: 487-487 [Full Text]  
• Katzenstein, D. A., Hammer, S. M., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., Merigan, T. C., Hirsch, M. S., The AIDS Clinical Trials Group Study 175 Virology, (1996). The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter. NEJM 335: 1091-1098 [Abstract] [Full Text]  
• Corey, L., Holmes, K. K. (1996). Therapy for Human Immunodeficiency Virus Infection -- What Have We Learned?. NEJM 335: 1142-1144 [Full Text]  
• Goldenberg, R. I., Bell, S. H., Wright, J., Brodeur, S. E., Turjanica, M. A., Beckman, L., Warker, N. (1996). HIV Continuum of Care: Challenges in Management. Home Health Care Management Practice 8: 1-10 [Abstract]